Premium
Preparing for sperm‐targeted contraception: College students’ perceptions and intentions related to non‐hormonal intravas injectable gel
Author(s) -
Buck Kirstin A.,
Stadick Jessica L.,
Frazier Marian L.
Publication year - 2020
Publication title -
public health nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 55
eISSN - 1525-1446
pISSN - 0737-1209
DOI - 10.1111/phn.12761
Subject(s) - promotion (chess) , long acting reversible contraception , hormonal contraception , medicine , vasectomy , family planning , family medicine , reproductive health , perception , gynecology , psychology , population , environmental health , research methodology , politics , political science , law , neuroscience
Objective The objective of the study was to evaluate college students’ perceptions and behavioral intentions related to a new long‐acting reversible contraceptive (LARC) for people with penises: non‐hormonal intravas injectable gel (NH‐IVIG). Design and Sample Data collection utilized predictive constructs from the theory of planned behavior. An online questionnaire surveyed undergraduates (ages 18–24 years) at a Midwestern, liberal arts college ( N = 460). Results Of potential NH‐IVIG users, 28.6% of males and 51.4% of females reported being overall likely to use or encourage its usage. The top three hypothetical NH‐IVIG promoters were low cost, reversibility, and infrequent administration. High cost, new product uncertainties, plus administration via injection for the males, were the most frequently cited NH‐IVIG deterrents. A majority of potential users indicated intentions to use protective barriers or other contraceptives simultaneously with NH‐IVIG; females were more likely overall. Most respondents (males, 90.4%; females, 98.5%) agreed all sexual partners should be equally responsible for contraception. Over half trusted both males and females to use contraception, but females were significantly more trusted and trusting. Conclusion Understanding factors influencing NH‐IVIG usage can direct initiatives for sperm‐targeted LARCs to mitigate risk behaviors and optimize public health promotion.